News | PB Leiner

PB LIVE webinar - Collagen supports joint health: Asian interest increases

WEBINAR Wednesday June 15, 2022, 2 PM SGT (8 AM CET). Joint health is a key concern for middle-aged consumers. Collagen peptides are gaining recognition as a joint health ingredient.

Event

PB LIVE @Vitafoods - Is collagen here to stay?

Collagen’s star is rising fast, but is it just a passing trend? A dive into the future of the collagen market with PB Leiner and Frost & Sullivan. According to an analysis conducted by the research firm Frost & Sullivan in collaboration with PB Leiner, one of the world’s leading collagen and gelatin producers, the market for collagen peptides is...

Event

Unique evidence: Joint pain reduced among active middle-aged adults taking SOLUGEL® collagen peptides

Vilvoorde, September 21, 2021 - A study examining joint pain in physically active middle-aged people has found that consuming SOLUGEL® collagen peptides can bring about significant reductions in pain and discomfort. This unique research was carried out by Florida State University (FSU) and commissioned by PB Leiner.

News

SOLUGEL download whitepaper collagen here to stay

Untapped potential: New report identifies collagen’s huge scope for further growth

Vilvoorde, April 22, 2021 - Collagen’s star is rising fast – but is it just a passing trend? Not according to industry experts, who say that this protein is set to become a major force in the health ingredients category.

News

PB Leiner’s newest product launch capitalizes on the latest health & nutrition trends

Vilvoorde, September 8, 2020 – PB Leiner proudly presents SOLUGEL® Dynamica, its exciting new collagen solution for functional bars and beverages, two applications that are typically challenging to produce. The new product will allow customers to easily formulate delicious trendy products that boast all the health benefits of collagen.

News

PB Leiner jumpstarts new pharma brand gelwoRx™ with two soft capsule specialty products

Vilvoorde, September 8, 2020 – PB Leiner introduces gelwoRx™, a new product family which it has created to effectively address the needs of the health care sector. The launch is being jumpstarted by the release of two soft capsule specialty products: gelwoRx™ Dsolve enhances the bioavailability of the capsule API by counteracting the natural...

News

PB Leiner enters the marine collagen market

Vilvoorde, August 27, 2020 - PB Leiner and Zhejiang Shengda Ocean Co., Ltd. from Zhoushan (P.R. China) have established a joint venture to construct a bone and marine collagen peptides plant. Under the terms of this agreement, PB Shengda (Zhejiang) Biotechnology Co., Ltd. will produce bone and marine collagen peptides based on PB Leiner’s...

News

PB Leiner opens new SOLUGEL™ production facility in Santa Fe

Vilvoorde, February 12, 2020 - PB Leiner (part of Tessenderlo Group) has inaugurated a new collagen peptides line today at its site in Santa Fe (Argentina). The added production facility will allow for a considerable extra production volume of SOLUGEL™ collagen peptides. “Global demand for collagen peptides is on the rise, on account of its...

News